These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25093471)

  • 1. Focus on addiction: Buspirone for cocaine relapse and monitoring controlled substances prescribed to dually diagnosed patients.
    Langleben DD
    J Clin Psychiatry; 2014 Jul; 75(7):748-9. PubMed ID: 25093471
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription drug monitoring program inquiry in psychiatric assessment: detection of high rates of opioid prescribing to a dual diagnosis population.
    Hackman DT; Greene MS; Fernandes TJ; Brown AM; Wright ER; Chambers RA
    J Clin Psychiatry; 2014 Jul; 75(7):750-6. PubMed ID: 25093472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence.
    Winhusen TM; Kropp F; Lindblad R; Douaihy A; Haynes L; Hodgkins C; Chartier K; Kampman KM; Sharma G; Lewis DF; VanVeldhuisen P; Theobald J; May J; Brigham GS
    J Clin Psychiatry; 2014 Jul; 75(7):757-64. PubMed ID: 24911028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing pharmacological treatments for cocaine dependence: Incorporation of methods for enhancing generalizability in meta-analytic studies.
    Susukida R; Crum RM; Hong H; Stuart EA; Mojtabai R
    Int J Methods Psychiatr Res; 2018 Dec; 27(4):e1609. PubMed ID: 29464791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating short- and long-term impacts of a Medicaid "lock-in" program on opioid and benzodiazepine prescriptions dispensed to beneficiaries.
    Naumann RB; Marshall SW; Lund JL; Gottfredson NC; Ringwalt CL; Skinner AC
    Drug Alcohol Depend; 2018 Jan; 182():112-119. PubMed ID: 29150151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.
    Collins GT; France CP
    Exp Clin Psychopharmacol; 2018 Oct; 26(5):488-496. PubMed ID: 29952618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
    de Oliveira Citó Mdo C; da Silva FC; Silva MI; Moura BA; Macêdo DS; Woods DJ; Fonteles MM; de Vasconcelos SM; de Sousa FC
    Behav Brain Res; 2012 May; 231(1):116-23. PubMed ID: 22374255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world.
    Winhusen T; Brady KT; Stitzer M; Woody G; Lindblad R; Kropp F; Brigham G; Liu D; Sparenborg S; Sharma G; Vanveldhuisen P; Adinoff B; Somoza E
    Contemp Clin Trials; 2012 Sep; 33(5):993-1002. PubMed ID: 22613054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing benzodiazepines for patients with substance use disorders.
    Lieberman DZ
    J Clin Psychiatry; 2004 Nov; 65(11):1577; author reply 1577-8. PubMed ID: 15554778
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncologists want FDA to rethink REMS.
    Goozner M
    J Natl Cancer Inst; 2010 Dec; 102(23):1748-9, 1751. PubMed ID: 21088276
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing diversion of controlled substances: Translating national guidelines into practice.
    Cobaugh DJ
    Am J Health Syst Pharm; 2017 Mar; 74(5):279. PubMed ID: 28213490
    [No Abstract]   [Full Text] [Related]  

  • 13. Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration.
    Ettenberg A; Bernardi RE
    Pharmacol Biochem Behav; 2006 Oct; 85(2):393-9. PubMed ID: 17064759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of clonidine antinociception by buspirone and 1-(2-pyrimidinyl)-piperazine.
    Cao BJ; Li WP
    Eur J Pharmacol; 1994 Jun; 259(1):75-8. PubMed ID: 7957598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chronic buspirone treatment on nicotine and concurrent nicotine+cocaine self-administration.
    Mello NK; Fivel PA; Kohut SJ
    Neuropsychopharmacology; 2013 Jun; 38(7):1264-75. PubMed ID: 23337868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of buspirone and gepirone on i.v. cocaine self-administration in rhesus monkeys.
    Gold LH; Balster RL
    Psychopharmacology (Berl); 1992; 108(3):289-94. PubMed ID: 1355922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dually diagnosed patient with psychotic symptoms.
    Ries RK
    J Addict Dis; 1993; 12(3):103-22. PubMed ID: 8251538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not DEA'd yet: Gonzales v. Oregon.
    Baron CH
    Hastings Cent Rep; 2006; 36(2):8. PubMed ID: 16604888
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
    Jordan CJ; Cao J; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine.
    Paine TA; Jackman SL; Olmstead MC
    Behav Pharmacol; 2002 Nov; 13(7):511-23. PubMed ID: 12409990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.